sur Catheter Precision, Inc
Catheter Precision to Attend International Atrial Fibrillation Symposium
Catheter Precision, Inc., a US-based medical device company listed on NYSE American as VTAK, announced its participation in the 30th International Atrial Fibrillation Symposium. This event will be held from January 16 to 18, 2025, in Boston, Massachusetts. Established in 1995, the symposium has grown into a significant scientific forum, providing healthcare professionals the chance to learn about developments in atrial fibrillation research and therapies.
According to David Jenkins, CEO of Catheter Precision, the symposium provides an opportunity for interaction with physicians in a focused environment, promoting their technologies and initiating new sales leads. The event also supports educational endeavors and peer-to-peer discussions about their products and clinical practices.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Catheter Precision, Inc